Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ramkhamhaeng Hospital PCLBKK:RAM-R 73 3-Year Revenue Growth Rate is 11.30% as of Jun. 2026, which is 58% above its 10-year median of 7.15. GuruFocus rates BKK:RAM-R with a GF Score™ of 73/100 and a GF Value™ of ฿42.29. The stock has 6 warning signs investors should review. Among 610 Healthcare Providers & Services companies, Ramkhamhaeng Hospital PCL ranks better than 64.26% on this metric.
During the past 12 months, Ramkhamhaeng Hospital PCL's average Revenue per Share Growth Rate was 96.40% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 11.30% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 6.90% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 16.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Ramkhamhaeng Hospital PCL was 45.50% per year. The lowest was -8.00% per year. And the median was 7.15% per year.
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.
Ramkhamhaeng Hospital PCL 3-Year Revenue Growth Rate Related Terms
BKK:RAM-R vs HCA, THC, EHC: 3-Year Revenue Growth Rate Comparison
For the Medical Care Facilities subindustry, Ramkhamhaeng Hospital PCL's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ramkhamhaeng Hospital PCL 3-Year Revenue Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ramkhamhaeng Hospital PCL's 3-Year Revenue Growth Rate distribution charts can be found below:
* The bar in red indicates where Ramkhamhaeng Hospital PCL's 3-Year Revenue Growth Rate falls into.
This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
What does a 3-Year Revenue Growth Rate of 11.30% mean?
Ramkhamhaeng Hospital PCL (BKK:RAM-R) has a 3-Year Revenue Growth Rate of 11.30% as of Jun. 2026. 3-Year Revenue Growth Rate is the 3-year average growth rate of Revenue per share. View historical data for Ramkhamhaeng Hospital PCL and its competitors. This is 58% above median its historical median of 7.15. According to the industry distribution chart, Ramkhamhaeng Hospital PCL ranks #218 out of 610 companies in the Healthcare Providers & Services industry, placing it in the top 35.7%.
Is Ramkhamhaeng Hospital PCL's 3-Year Revenue Growth Rate too high?
Ramkhamhaeng Hospital PCL's current 3-Year Revenue Growth Rate of 11.30% is 58% above median its 10-year median of 7.15. The Healthcare Providers & Services industry median 3-Year Revenue Growth Rate is 7.00. Ramkhamhaeng Hospital PCL's value of 11.30% is 61.4% above this industry median. Based on the distribution chart, Ramkhamhaeng Hospital PCL ranks #218 out of 610 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Ramkhamhaeng Hospital PCL has a GF Score™ of 73/100, reflecting its overall financial health beyond just this single metric.
How does Ramkhamhaeng Hospital PCL's 3-Year Revenue Growth Rate compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ramkhamhaeng Hospital PCL ranks #218 out of 610 companies for 3-Year Revenue Growth Rate. This puts Ramkhamhaeng Hospital PCL in the upper half of its industry. The industry median 3-Year Revenue Growth Rate is 7.00. Ramkhamhaeng Hospital PCL's value of 11.30% is 61.4% above this benchmark. While the company's 10-year median is 7.15 vs. the industry median of 7.00, Ramkhamhaeng Hospital PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Revenue Growth Rate for a Healthcare Providers & Services company?
The median 3-Year Revenue Growth Rate among Healthcare Providers & Services companies is 7.00, based on 610 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Revenue Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Revenue Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ramkhamhaeng Hospital PCL's current 3-Year Revenue Growth Rate of 11.30% is 61.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Revenue Growth Rate mean?
A high 3-Year Revenue Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Revenue Growth Rate is the 3-year average growth rate of Revenue per share. View historical data for Ramkhamhaeng Hospital PCL and its competitors. For the Healthcare Providers & Services industry, the median 3-Year Revenue Growth Rate is 7.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ramkhamhaeng Hospital PCL's current 3-Year Revenue Growth Rate is 11.30%, which is 58% above median its own 10-year median of 7.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ramkhamhaeng Hospital PCL stock overvalued right now?
Ramkhamhaeng Hospital PCL (BKK:RAM-R) has a current 3-Year Revenue Growth Rate of 11.30%. The stock's GF Value™ is ฿42.29, compared to a current price of ฿17.40 — trading 58.9% below its estimated fair value. The current 3-Year Revenue Growth Rate is 11.30%, which is 58% above median its 10-year median of 7.15 and 61.4% above the Healthcare Providers & Services industry median of 7.00. Ramkhamhaeng Hospital PCL's overall GF Score™ is 73/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Revenue Growth Rate calculated?
3-Year Revenue Growth Rate is calculated from a company's financial statements. For Ramkhamhaeng Hospital PCL (BKK:RAM-R), the current 3-Year Revenue Growth Rate is 11.30% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ramkhamhaeng Hospital PCL (BKK:RAM-R) Overvalued in 2026?
Based on GuruFocus' analysis, Ramkhamhaeng Hospital PCL stock appears to be undervalued.
The current stock price of ฿17.40 is trading 58.9% below its estimated GF Value™ of ฿42.29.
Key valuation signals for BKK:RAM-R:
3-Year Revenue Growth Rate: 11.30% (58% above median its 10-year median of 7.15)
GF Value™: ฿42.29 vs. price of ฿17.40 (58.9% below fair value)
Industry Position: 61.4% above the Healthcare Providers & Services median (#218 of 610)
No single metric tells the full story. See the BKK:RAM-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ramkhamhaeng Hospital PCL business activities are hospital and businesses that support medical care. The company provides medical treatment for all types of diseases by physicians and medical professionals in all specialties. Its medical services include the 24-hour Heart Center, RAM Pituitary Center for laparoscopic surgery for pituitary tumors, Neurology & Neurosurgery Center, and specialized medical centers such as Eye Clinic, Ear, Nose and Throat Clinic, Gastroenterology Clinic, Obstetrics and Gynecology Clinic, and Diabetes Clinic. The company operates through two segments: Hospital, which includes General Hospital and Hospital in Social Security and generates the maximum revenue; and Others, which includes sale of medical equipment and instruments. Its operations are in Thailand.
73GF Score
Get the complete analysis for BKK:RAM-R
3-Year Revenue Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:RAM-R has been successfully added to your 
